Skip to main content
NewNMC’s advertising guidelines for doctors are in force from 6 Oct 2026. See what to change, and get a free compliance auditNew NMC advertising rules for doctors: what to change
AI Search

How Pharma Brands Appear in AI Answers: An Accuracy and Compliance Audit

A method for auditing how AI assistants describe a prescription brand: wrong indications, missing safety context, which sources they cite, and which corrective pages a company can publish within promotion rules.

How Pharma Brands Appear in AI Answers: An Accuracy and Compliance Audit

When a patient or a prescriber asks an AI assistant about a branded medicine, the answer is composed from whatever the system retrieved or remembers. It may describe the brand correctly. It may also attach an indication the brand is not approved for, merge it with a competitor, quote an old dosage or leave out a safety warning. For a pharma company in India, that raises two questions at once: is the answer accurate, and what is the company allowed to do about it?

This article is for brand managers, medical affairs, regulatory affairs and digital leads at pharmaceutical companies. It is a teardown method, not a set of findings. Results depend on the molecule, the market and the day, so we describe how to run the audit and read it, and we do not report numbers. Everything here assumes your regulatory and medical teams review each step. Our pharma marketing guide covers the wider channel context.

Set the boundary before you start

Two rules shape the whole exercise.

First, the audit is observational. You are recording what AI systems say. You are not trying to make them say promotional things. Wording that would be a problem on your own page is no less a problem because an AI is repeating it.

Second, compliance work comes before publication work. In India, the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 restricts advertisements of drugs for specified purposes and prohibits misleading drug advertisements. The Department of Pharmaceuticals' UCPMP 2024 portal describes the code as mandatory, sets ethical norms for company interactions with healthcare practitioners, and runs enforcement through association ethics committees with appeals to the Department. That portal text covers industry and practitioner interactions and does not address public advertising, so confirm with regulatory counsel how each rule applies to a given page and audience. Prescription brands generally need extra care in what is shown to the public. This article does not give legal advice.

Build the query set

Draft about fifty queries, split by who is asking. Keep wording natural and avoid anything resembling a real patient's circumstances.

GroupExample pattern (use your own brand)What you are testing
Brand name only"What is [Brand]?"Basic identity: molecule, class, manufacturer
Brand and indication"Is [Brand] used for [condition]?"Correctness of approved indications
Brand and safety"[Brand] side effects", "[Brand] and pregnancy"Presence and accuracy of warnings
Brand and dose"[Brand] dose for adults"Whether the answer offers dosing without prescriber context
Brand versus comparator"[Brand] vs [competitor brand]"Comparative claims and sources
Generic and brand"[Molecule] brands in India"Whether the brand appears, and how
Availability"Where to buy [Brand]", "[Brand] price India"Retail and pricing information, which changes
Professional framing"Prescribing information [Brand]"Whether the official document is reached

Run each query on the assistants your audience uses, with search and browsing turned on and off if the product allows it, and repeat each three times because answers vary. Record the date, surface, mode and full text. Do not enter real patient details into any tool.

Score each answer on five checks

Have a pharmacist or medical affairs reviewer score the answers, not the marketing team. Use a simple sheet.

  1. Identity. Is the molecule, strength range, dosage form and manufacturer correct?
  2. Indications. Does the answer list only approved indications? Flag extra, missing and off-label ones separately, because off-label content can be a safety concern even when medically plausible.
  3. Safety context. Are contraindications and key warnings present, and is there any statement that could be read as reassurance beyond the label?
  4. Currency. Does the answer reflect the current label, or an older version, a withdrawn strength or a discontinued presentation?
  5. Sources. Which URLs were cited or clearly used? Classify each as company, regulator, hospital, medical reference, pharmacy retailer, forum, news or unknown.

Record severity as well. A wrong manufacturer name is minor. A wrong indication, a missing contraindication or a dosing statement presented as advice is a potential patient-safety issue and goes to medical and pharmacovigilance leads the same day.

Read the source pattern

The most useful output of the audit is usually not the errors. It is the list of pages the AI relied on. Group them.

  • Retailer and e-pharmacy pages. Often carry short, template-generated descriptions that may be outdated. You may not control them, but you can supply accurate information through legitimate channels.
  • Third-party health information sites. Check whether their text is consistent with the current label.
  • Forums and community threads. These carry personal experience and rumour. You should not edit or astroturf them. Reddit and similar communities have their own rules and expect disclosure of affiliation.
  • Company pages. Is your prescribing information reachable and indexable, or hidden behind a script, a login or a PDF with no text layer?
  • Regulator pages. Are the relevant regulator pages cited for your brand, or are older documents dominant?

A hypothetical illustration: the audit finds that for a fictional brand "Brandex", three of four assistants describe an indication that was removed from the label several years ago, and every one cites the same retailer page. The fix is not another blog post. It is to correct the retailer's source information through the supply chain and to publish a clear, current label page that can be retrieved.

What a company can do, within promotion rules

Options, in rough order of safety:

  1. Publish current, accessible prescribing information. Put the approved label on a crawlable page, with the text in HTML, not only in an image or a PDF. Add the revision date. Make sure the page is clearly labelled for healthcare professionals if that is its audience, and follow your regulatory team's rules about access.
  2. Keep a medical information page that states facts only. Brand name, molecule, class, approved indications, key safety information and a route to the medical information team. No superlatives, no comparative claims, no outcome language.
  3. Use structured data conservatively. schema.org's Drug type includes activeIngredient, prescriptionStatus, warning, manufacturer and brand. Marking up facts that already appear in the label helps systems read them unambiguously. Do not use markup to add claims that the page text does not carry.
  4. Correct third-party sources. Contact retailers, aggregators and reference sites with the current label and ask them to update. Keep a log of requests and replies.
  5. Use platform feedback channels for factual errors. Google documents a way to report problems with an AI Overview through the thumbs-down control. Other assistants have in-product feedback tools too. Give a plain factual description, cite the label and avoid promotional language. These channels do not guarantee a change.
  6. Escalate safety-significant errors internally first. If an answer states something that could cause harm, medical and regulatory teams decide on wording and routing.

What not to do: do not publish a page whose purpose is to be quoted by AI with claims you could not make elsewhere. Do not seed forums. Do not write comparative content that has not passed your normal review.

Want this applied to your practice? Get a free ai search audit.

Book my free audit

Pharmacovigilance and the audit

If reviewers see content in an answer that reads like an adverse event report, for example a user describing a reaction in a follow-up, route it through the company's pharmacovigilance process as the standard operating procedure requires. Agree beforehand with the pharmacovigilance lead whether audit activity could create reportable information, and document the decision.

Reporting to the brand and regulatory teams

Give each brand a one-page summary:

  • Surfaces and dates tested, number of runs.
  • Count of answers by check, by severity.
  • The top five cited sources, with their owner and what is wrong with them.
  • The corrective actions, owners and dates.
  • A repeat date, usually quarterly, or after label changes.

Avoid headline scores that suggest false precision. A table of specific wrong statements with their sources is easier to act on than an accuracy percentage.

Failure modes

  • Marketing scoring clinical accuracy. Keep clinical judgement with medical staff.
  • Treating one run as the truth. Answers differ between runs and between surfaces.
  • Chasing every wrong forum post. Prioritise by safety severity and by how often a source appears.
  • Publishing fixes faster than approvals. A corrective page that has not passed review creates its own problem.
  • Forgetting HCP and public separation. The label page for professionals and a patient information page serve different audiences and may have different access rules.
  • Ignoring the generic and molecule queries. Many users ask by molecule, where your brand may be absent altogether.

Repeat after label changes

Every label update, new indication, safety communication or presentation change should trigger a re-run of the relevant query group within a few weeks. AI systems and retail pages lag behind labels, and the lag is when wrong statements circulate.

AiLLMz organises citations and publication workflows that support visibility across AI search and LLMs, and may help manage the source-correction log, but approval of every statement remains with your regulatory team. For wider context, see our pages on pharmaceutical industry marketing and pharma digital marketing, and our schema markup service.

Where to start

  • Pick one brand and agree scope with regulatory and medical affairs.
  • Draft the query set and have a pharmacist review the wording.
  • Run three repeats per query on each surface and save full text.
  • Score the five checks and sort by severity.
  • List the sources and decide which ones you can legitimately correct.
  • Fix your own label page first, then the third-party sources.
Filed underAI answers drug brandpharma brand AI search auditAI wrong indication drugpharma generative search compliancebrand drug information ChatGPT

About the author

Co-Founder & CTO · Gurugram, India

Arush builds the systems the rest of the company runs on — the patient-acquisition pipelines, the AI chatbots, the analytics that tie a single click to a booked appointment. If a campaign reports a number, it's because something his team built is tracking it.

Free guide · 15 pages

The Patient Acquisition Blueprint

A 90-day plan from first search to booked appointment.

The Pioneers Brief — one essay, three benchmarks, one teardown, every Thursday. Subscribe free →

Free ai search audit

Your next chapter starts with a conversation.

Three quick questions. We come prepared with a plan for your specialty and city.

  • A 30-minute call with a healthcare specialist
  • Your top three growth opportunities, in writing
  • Honest advice — even if that means not hiring us
  • No obligation and no hard sell
You’ll speak with a senior strategist
Consultations are hosted by Arush Thapar’s team.
Step 1 of 3Takes 30 seconds

What do you want to improve first?

Details stay privateNo obligationReply within 1 working day

Client portfolio · Healthcare websites

Work relevant to how pharma brands appear in ai answers an accuracy and.

Explore client work →